Xeris Biopharma Holdings (XERS) Interest Coverage Ratio (2020 - 2026)

Xeris Biopharma Holdings has reported Interest Coverage Ratio for 7 years, with the latest figure at 1.15 in Q1 2026.

• For the quarter ending Q1 2026, Interest Coverage Ratio rose 371.22% year-over-year to 1.15; the trailing twelve-month figure through Mar 2026 stood at 1.25 (up 270.91% YoY), and the FY2025 full-year result was 0.86, up 177.56% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 1.15, down from 2.34 in the prior quarter.
• The five-year high for Interest Coverage Ratio was 2.34 in Q4 2025, with the low at 8.31 in Q1 2022.
• Historically, Interest Coverage Ratio has averaged 1.69 across 5 years, with a median of 1.41 in 2023.
• Annual changes were most pronounced in 2024 — Interest Coverage Ratio tumbled 130.78% — and 2025, when it jumped 973.29%.
• Xeris Biopharma Holdings' Interest Coverage Ratio stood at 3.48 in 2022, then jumped by 59.55% to 1.41 in 2023, then surged by 115.54% to 0.22 in 2024, then jumped by 973.29% to 2.34 in 2025, then slumped by 51.07% to 1.15 in 2026.
• The last three Interest Coverage Ratio figures came in at 1.15 (Q1 2026), 2.34 (Q4 2025), and 0.92 (Q3 2025), per Business Quant data.